Boehringer, Lilly (LLY) Phase IIb of SGLT-2 Shows Significant Reduction in SBP

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. FMG:AU

Go back to Boehringer, Lilly (LLY) Phase IIb of SGLT-2 Shows Significant Reduction in SBP
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1263.62 +19.22 (1.54%)
Previous Close $1244.40    52 Week High $88.16 
Open $1232.00    52 Week Low $67.88 
Day High $1271.22    P/E 292.50 
Day Low $1230.00    EPS $4.32 
Volume 1,087,260